Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
Chikh A, Ferro R, Abbott JJ, Piñeiro R, Buus R, Iezzi M, Ricci F, Bergamaschi D, Ostano P, Chiorino G, Lattanzio R, Broggini M, Piantelli M, Maffucci T, Falasca M.
Chikh A, et al. Among authors: falasca m.
Oncotarget. 2016 Apr 5;7(14):18325-45. doi: 10.18632/oncotarget.7761.
Oncotarget. 2016.
PMID: 26934321
Free PMC article.